Adenovirus-Mediated Thymidine Kinase Gene Therapy for Recurrent Ovarian Cancer: Expression of Coxsackie-Adenovirus Receptor and Integrins αvβ3 and αvβ5

被引：0
|
作者：
A. Hasenburg
D.-C. Fischer
X.-W. Tong
A. Rojas-Martinez
R. H. Kaufman
I. Ramzy
P. Kohlberger
M. Orlowska-Volk
E. Aguilar-Cordova
D. G. Kieback
机构：
[1] University Medical Center,Department of Obstetrics and Gynecology 1, Department of Pathology
[2] Baylor College of Medicine,Department of Obstetrics and Gynecology, Department of Pediatrics/Hematology
[3] Harvard Gene Therapy Initiative,Oncology, and Department of Pathology
[4] University Medical Center,Department of Obstetrics and Gynecology
来源：
The Journal of the Society for Gynecologic Investigation: JSGI | 2002年 / 9卷 / 3期
关键词：
Recurrent ovarian cancer; thymidine kinase gene therapy; intraperitoneal therapy; CAR; integrins αvβ3 and αvβ5;
D O I：
10.1177/107155760200900310
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：174 / 180
页数：6
相关论文
共 50 条
  • [31] Coxsackie-adenovirus-receptor is co-localized with integrins αVβ3 and αVβ5 on human cardiac myocyte sarcolemma and upregulated in dilated cardiomyopathy:: Implications for viral pathogenesis and gene therapy
    Poller, WC
    Noutsias, M
    Fechner, H
    Wang, X
    Houtsmuller, AB
    De Jonge, H
    Schultheiss, HP
    Lamers, JM
    CIRCULATION, 2000, 102 (18) : 201 - 201
  • [32] Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents
    Tong, XW
    Shine, DH
    Agoulnik, I
    Freund, CTF
    Hasenburg, A
    Aguilar-Cordova, E
    Woo, SLC
    Kieback, DG
    ANTICANCER RESEARCH, 1998, 18 (5A) : 3421 - 3426
  • [33] The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy
    Okegawa, T
    Li, YM
    Pong, RC
    Bergelson, JM
    Zhou, J
    Hsieh, JT
    CANCER RESEARCH, 2000, 60 (18) : 5031 - 5036
  • [34] The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter
    Tong, XW
    Engehausen, DG
    Freund, CTF
    Agoulnik, I
    Guo, ZS
    Oehler, MK
    Kim, TE
    Hasenburg, A
    Contant, CF
    Woo, SLC
    Kieback, DG
    ANTICANCER RESEARCH, 1998, 18 (2A) : 719 - 725
  • [35] Efficacy of intraperitoneal adenovirus-mediated p53 gene therapy in ovarian cancer
    Von Gruenigen, VE
    O'Boyle, JD
    Coleman, RL
    Wilson, D
    Miller, DS
    Mathis, JM
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (05) : 365 - 372
  • [36] Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells
    Nalbantoglu, J
    Pari, G
    Karpati, G
    Holland, PC
    HUMAN GENE THERAPY, 1999, 10 (06) : 1009 - 1019
  • [37] Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer
    Yee, D
    McGuire, SE
    Brunner, N
    Kozelsky, TW
    Allred, DC
    Chen, SH
    Woo, SLC
    HUMAN GENE THERAPY, 1996, 7 (10) : 1251 - 1257
  • [38] The levels of integrin αvβ5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells
    Takayama, K
    Ueno, H
    Pei, XH
    Nakanishi, Y
    Yatsunami, J
    Hara, N
    GENE THERAPY, 1998, 5 (03) : 361 - 368
  • [39] The levels of integrin αvβ5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells
    K Takayama
    H Ueno
    X-H Pei
    Y Nakanishi
    J Yatsunami
    N Hara
    Gene Therapy, 1998, 5 : 361 - 368
  • [40] Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy combined with ganciclovir induces hepatoma cell apoptosis
    Zhang, Haitao
    Qin, Ling
    Li, Chaolu
    Jiang, Jianyi
    Sun, Libo
    Zhao, Xiaofei
    Li, Ning
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) : 1649 - 1655
12345